Camsing Healthcare Limited

Camsing Healthcare Limited

SSGX:BAC
0.12
SGD
+0.00
(+2.59%)
-0.01EPS
9.66MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.54
0.53
0.47
0.61
0.5
0.28
0.24
0.19
0.18
0.2
0.16
0.07
0.05
0.03
Basic EPS, GAAP
-0.04
0.01
-0.07
0.01
- -
-0.22
-0.18
-0.03
-0.04
-0.08
-0.09
-0.04
-0.01
-0.01
Free Cash Flow per Basic Share
-0.06
-0.02
-0.05
0.01
- -
-0.08
0.09
0.07
0.02
-0.02
0.01
-0.02
- -
-0.01
Dividend per Share
0.02
0.06
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.48
0.44
0.35
0.36
0.37
0.14
-0.04
-0.07
-0.11
-0.19
-0.28
-0.06
-0.07
-0.05
Tangible Book Value per Share
0.48
0.44
0.35
0.36
0.37
0.14
-0.04
-0.07
-0.11
-0.19
-0.28
-0.06
-0.07
-0.05
Basic Weighted Avg Shares
30
30
30
30
30
30
30
30
30
30
30
65
90
102
Sales/Revenue/Turnover
16
16
14
18
15
8
7
6
6
6
5
5
4
4
Operating Margin (%)
-5.3
2.77
-14.99
-3.2
-2.17
-39.02
-52.86
-23.97
-31.66
-32.77
-40.15
-52.58
-33.3
-39.96
Depreciation Expense
- -
- -
- -
- -
- -
- -
3
2
1
1
1
1
- -
- -
Net Income, GAAP
-1
- -
-2
- -
- -
-7
-5
-1
-1
-2
-3
-2
-1
-1
Effective Tax Rate (%)
- -
13.61
- -
1.83
94.26
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-6.88
2.77
-14
0.88
0.36
-78.34
-74.69
-14.55
-24.01
-39.41
-56.1
-48.13
-22.61
-28.69
Working Capital
11
10
8
8
8
2
-3
-3
-4
-7
-9
-3
-5
-5
LT Debt
- -
- -
- -
- -
- -
- -
2
1
2
1
- -
2
1
2
Total Equity
14
13
11
11
11
4
-1
-2
-3
-6
-8
-5
-6
-7
Return on Invested Capital (%)
- -
2.35
- -
-3.98
-0.13
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
3.52
- -
2
0.69
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-7.38
3.18
-16.67
1.5
0.48
-85.91
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

SGD

•

in mil. unless spec.
Jan'26
Apr'27
Jul'27
ST Debt
3
3
3
LT Borrowings
1
1
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
90
90
140
Market Capitalization
3
- -
10

Working Capital

SGD

•

in mil. unless spec.
Jan'26
Apr'27
Jul'27
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
6
6
Payables & Accruals
- -
- -
- -
ST Debt
3
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.79%
32.88%
17.64%
Free Cash Flow
-353.87%
-218.11%
-74.59%
Net Income, GAAP
-1,269.37%
15.91%
-59.69%
Sales/Revenue/Turnover
-9.65%
-5.71%
-14.18%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1
2
1
1
5
2026
1
1
1
1
4
2027
1
1
- -
- -
- -

Quarterly Earnings Per Share

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.02
0.01
- -
-0.02
-0.04
2026
-0.01
- -
- -
- -
-0.01
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Sector
Retail trade
Industry
Specialty stores
Address
Singapore Singapore
IPO Date
May 22, 1980
Business
Camsing Healthcare Limited is an investment holding company that engages in the distribution, wholesaling, and retailing of health foods, nutritional supplements, personal care products, and healthcare equipment. The company operates primarily through its core operating subsidiary, Nature's Farm Pte Ltd, catering to retail consumers, health-conscious individuals, and commercial clients across Singapore and neighboring Southeast Asian markets. Its comprehensive product and service portfolio includes vitamins and minerals such as multivitamins, vitamin C, vitamin D, and B-complex formulations; dietary and wellness supplements comprising omega-3 fish oils, probiotics, antioxidants, digestive enzymes, and weight management products; beauty and anti-aging treatments encompassing collagen drinks, skin brightening capsules, and hyaluronic acid formulations; natural bee products including premium Manuka honey, royal jelly, and propolis extracts; traditional and herbal remedies including lingzhi, cordyceps, and standardized botanical extracts; joint and bone care formulations comprising glucosamine, chondroitin, and calcium complexes; as well as organic foods, personal care items, and health diagnostic accessories. The company distributes its offerings under proprietary house brands, including Nature's Farm, Food Source, and Royal Essence, alongside distributed third-party international wellness brands through a network of specialty retail stores, departmental concessions, and direct-to-consumer e-commerce channels. Originally founded in 1979 as Jacks International Limited and headquartered in Singapore, the organization adopted its current name in 2016 following a change in controlling ownership. In recent developments, Camsing Healthcare has focused on comprehensive corporate and financial restructuring initiatives to address historical legacy issues, restructure outstanding liabilities, and work toward the resumption of trading on the Singapore Exchange. Operational and strategic changes include reconstituting the board of directors and executive leadership, optimizing its brick-and-mortar retail footprint, enhancing omnichannel digital sales platforms, negotiating with potential strategic investors for capital injection, and introducing new immune-support and functional wellness product lines to strengthen core retail performance.